3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Conditions
Neoplasms
15
Papillomavirus Infections
9
Uterine Cervical Neoplasms
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Neuroendocrine Tumors
3
Neoplasm Metastasis
3
Myasthenia Gravis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Autoimmune Diseases
3
Thyroid Diseases
2
Pancreatic Cyst
2
Neuroblastoma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Abortion, Spontaneous
2
Interventions
Microarray Analysis
2
Immunoenzyme Techniques
2
Data Collection
2
Vascular Endothelial Growth Factor A
1
Tomography, Optical Coherence
1
Tissue Banks
1
Polymerase Chain Reaction
1
Pemetrexed
1
Mitoxantrone
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Flow Cytometry
1
Drug Therapy
1
Blood Specimen Collection
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Mesothelioma, Malignant
×
Data Collection
×
Clear all
NCT05308966
2025-10-06
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
Completed
204 enrolled
NCT04775446
2022-02-04
MESOIMMUNE
Centre Hospitalier Intercommunal Creteil
Completed
116 enrolled